Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

129Xenon MR Imaging and Spectroscopy Response to Sotatercept in Pulmonary Arterial Hypertension

NCT06351345 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT06351345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06351345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
129Xenon MR Imaging and Spectroscopy Response to Sotatercept in Pulmonary Arterial Hypertension
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Recruiting
Start date
October 27, 2025
Completion date
February 4, 2030
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, pulmonary hypertension